Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.585% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1cccnc1NC(=O)c1cc2c(=O)oc3ccccc3c2s1
b. CC1CCCN(C(=O)c2ccc(NC(=O)CC3SC(N4CCCC4)=NC3=O)cc2)C1
Answer: a. Cc1cccnc1NC(=O)c1cc2c(=O)oc3ccccc3c2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccnc1NC(=O)c1cc2c(=O)oc3ccccc3c2s1
Cc1cccnc1NC(=O)c1cc2c(=O)oc3ccccc3c2s1
N-(3-methylpyridin-2-yl)-4-oxothieno[3,2-c]chromene-2-carboxamide